Genelux Corporation (GNLX) vs NRx Pharmaceuticals, Inc. (NRXP)
A side-by-side comparison of Genelux Corporation and NRx Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GNLX
Genelux Corporation
$2.59HealthcareDelayed quote: Oct 6, 2026, 12:48 PM EDT
NRXP
NRx Pharmaceuticals, Inc.
$2.90HealthcareDelayed quote: Oct 6, 2026, 12:49 PM EDT
Total return — GNLX vs NRXP
growth of $100 · dividends reinvested · last 4yGNLX -57.7% (-19.4%/yr)NRXP -77.6% (-31.2%/yr)GNLX compounded faster over this window
GNLX NRXP
GNLX vs NRXP: by the numbers
- •NRXP is the larger company ($126M vs $116M market cap).
- •Both run net losses; NRXP's is the smaller (-691.81% vs -422412.50% net margin).
Metrics side by side
Valuation
| Metric | GNLX | NRXP |
|---|---|---|
| P/S ratio | 14517.08 | 36.99 |
| P/B ratio | 7.21 | N/A |
Profitability
| Metric | GNLX | NRXP |
|---|---|---|
| Gross margin | -7075.00% | 58.78% |
| Operating margin | -415175.00% | -1324.41% |
| Net margin | -422412.50% | -691.81% |
| ROE | -209.73% | N/A |
| ROIC | -192.18% | N/A |
Growth (annualized)
| Metric | GNLX | NRXP |
|---|---|---|
| Total return CAGR (5Y) | N/A | -49.61% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.